Literature DB >> 10630516

Acute liver failure after treatment with nefazodone.

M I Lucena1, R J Andrade, A Gomez-Outes, M Rubio, M R Cabello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10630516     DOI： 10.1023/a:1026620029470

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Acute cholestasis by fluoxetine.

Authors:  A Cosme; J Barrio; C Lobo; I Gil; A Castiella; J I Arenas
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

Review 2.  Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.

Authors:  S Caccia
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

Review 3.  The safety profile of nefazodone.

Authors:  D S Robinson; D L Roberts; J M Smith; J C Stringfellow; S B Kaplita; J A Seminara; R N Marcus
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

Review 4.  Acute liver failure.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

5.  Trazodone and liver toxicity.

Authors:  A G Chu; B L Gunsolly; R W Summers; B Alexander; C McChesney; V L Tanna
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

6.  Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.

Authors:  R H Barbhaiya; A B Buch; D S Greene
Journal:  Br J Clin Pharmacol       Date:  1996-11       Impact factor: 4.335

Review 7.  Hepatotoxicity.

Authors:  H J Zimmerman
Journal:  Dis Mon       Date:  1993-10       Impact factor: 3.800
  7 in total
  4 in total

1.  Drug-Induced Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 2.  Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists.

Authors:  Raúl-J Andrade; Mercedes Robles; Alejandra Fernández-Castañer; Susana López-Ortega; M-Carmen López-Vega; M-Isabel Lucena
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 3.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 4.  Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.

Authors:  Sanja Dragovic; Nico P E Vermeulen; Helga H Gerets; Philip G Hewitt; Magnus Ingelman-Sundberg; B Kevin Park; Satu Juhila; Jan Snoeys; Richard J Weaver
Journal:  Arch Toxicol       Date:  2016-09-22       Impact factor: 5.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.